http://www.medpagetoday.com/Psychiatry/GeneralPsychiatry/tb/3708
Metabolic Syndrome Risk Doubles With Schizophrenia Drug
In a study evaluating patients with schizophrenia or schizoaffective
disorder taking Clozaril, more than half had metabolic syndrome symptoms,
compared with only one-fifth of matched controls, said psychiatrist J.
Steven Lamberti, M.D., of the University of Rochester (N.Y.) Medical Center.
www.peoplewho.org